These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16253777)

  • 1. Clusterin as a therapeutic target for radiation sensitization in a lung cancer model.
    Cao C; Shinohara ET; Li H; Niermann KJ; Kim KW; Sekhar KR; Gleave M; Freeman M; Lu B
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1228-36. PubMed ID: 16253777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer.
    Cao C; Mu Y; Hallahan DE; Lu B
    Oncogene; 2004 Sep; 23(42):7047-52. PubMed ID: 15258565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer.
    Cao C; Shinohara ET; Niermann KJ; Donnelly EF; Chen X; Hallahan DE; Lu B
    Mol Cancer Ther; 2005 Aug; 4(8):1137-45. PubMed ID: 16093429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
    Sowery RD; Hadaschik BA; So AI; Zoubeidi A; Fazli L; Hurtado-Coll A; Gleave ME
    BJU Int; 2008 Aug; 102(3):389-97. PubMed ID: 18336596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.
    Kususda Y; Miyake H; Gleave ME; Fujisawa M
    Br J Cancer; 2012 Jun; 106(12):1945-52. PubMed ID: 22588555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer.
    Lamoureux F; Thomas C; Yin MJ; Kuruma H; Beraldi E; Fazli L; Zoubeidi A; Gleave ME
    Cancer Res; 2011 Sep; 71(17):5838-49. PubMed ID: 21737488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.
    Tang Y; Liu F; Zheng C; Sun S; Jiang Y
    J Exp Clin Cancer Res; 2012 Sep; 31(1):73. PubMed ID: 22967941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer.
    Chi KN; Eisenhauer E; Fazli L; Jones EC; Goldenberg SL; Powers J; Tu D; Gleave ME
    J Natl Cancer Inst; 2005 Sep; 97(17):1287-96. PubMed ID: 16145049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo.
    So A; Sinnemann S; Huntsman D; Fazli L; Gleave M
    Mol Cancer Ther; 2005 Dec; 4(12):1837-49. PubMed ID: 16373699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer.
    Chi KN; Siu LL; Hirte H; Hotte SJ; Knox J; Kollmansberger C; Gleave M; Guns E; Powers J; Walsh W; Tu D; Eisenhauer E
    Clin Cancer Res; 2008 Feb; 14(3):833-9. PubMed ID: 18245546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
    Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
    Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model.
    Nishikawa M; Miyake H; Gleave M; Fujisawa M
    Target Oncol; 2017 Feb; 12(1):69-79. PubMed ID: 27526062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma.
    Lamoureux F; Baud'huin M; Ory B; Guiho R; Zoubeidi A; Gleave M; Heymann D; Rédini F
    Oncotarget; 2014 Sep; 5(17):7805-19. PubMed ID: 25138053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer.
    Miyake H; Hara I; Fujisawa M; Gleave ME
    Expert Opin Investig Drugs; 2006 May; 15(5):507-17. PubMed ID: 16634689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.
    Gleave M; Miyake H
    World J Urol; 2005 Feb; 23(1):38-46. PubMed ID: 15770517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
    Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
    Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.
    Muramaki M; So A; Hayashi N; Sowery R; Miyake H; Fujisawa M; Gleave ME
    BJU Int; 2009 Feb; 103(3):384-90. PubMed ID: 19007378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.
    Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME
    Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma.
    Hadchity E; Aloy MT; Paulin C; Armandy E; Watkin E; Rousson R; Gleave M; Chapet O; Rodriguez-Lafrasse C
    Mol Ther; 2009 Aug; 17(8):1387-94. PubMed ID: 19436268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.
    Yamanaka K; Gleave M; Muramaki M; Hara I; Miyake H
    Oncol Rep; 2005 May; 13(5):885-90. PubMed ID: 15809754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.